Cargando…

Editorial: Drug re-purposing for the treatment of bacterial infections

Detalles Bibliográficos
Autores principales:	Tomás, María, Smani, Younes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389312/ https://www.ncbi.nlm.nih.gov/pubmed/35991896 http://dx.doi.org/10.3389/fphar.2022.973730

Ejemplares similares

Editorial: Drug Re-purposing for the Treatment of Bacterial and Viral Infections
por: García-Contreras, Rodolfo, et al.
Publicado: (2019)

Editorial: Antivirulence Drugs Against Bacterial Infections
por: Imperi, Francesco, et al.
Publicado: (2021)

Drug Repurposing for the Treatment of Bacterial and Fungal Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2019)

Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2022)

Editorial: Phytochemicals targeting autophagy in treatment of bacterial infection and malignancies
por: Bai, Xiaoxue, et al.
Publicado: (2023)

Editorial: The use of real world data for regulatory purposes in the rare diseases setting
por: Giannuzzi, Viviana, et al.
Publicado: (2022)

Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
por: Lautié, Emmanuelle, et al.
Publicado: (2020)

Editorial: Re-emergence of natural products for drug discovery in honor of Prof. Dr. M. Iqbal Choudhary
por: Hussain, Hidayat, et al.
Publicado: (2023)

Editorial: Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases
por: Li, Xiaohui, et al.
Publicado: (2022)

Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19
por: Rajaiah, Rajesh, et al.
Publicado: (2020)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs
por: Koltai, Tomas
Publicado: (2015)

Editorial: Structure-Based Drug Design for Diagnosis and Treatment of Neurological Diseases
por: Ramsay, Rona R., et al.
Publicado: (2017)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Editorial: Advances in Drug Formulation
por: Mukherjee, Biswajit, et al.
Publicado: (2020)

Editorial: Therapeutic potential of natural products-based drugs in regulation of lipid metabolism
por: Rašković, Aleksandar, et al.
Publicado: (2023)

Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections
por: Principi, Nicola, et al.
Publicado: (2019)

Editorial: Evidence for Assessing Drug Safety and Drug Use in Older People
por: Lopes, Luciane Cruz, et al.
Publicado: (2022)

Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes
por: Rasouli, Hassan, et al.
Publicado: (2023)

Editorial: Drug-induced immunogenic cell death patterns and anti-cancer treatment
por: Xia, Xianghou, et al.
Publicado: (2023)

Editorial: Metalloenzymes: Potential Drug Targets
por: Iqbal, Jamshed, et al.
Publicado: (2021)

Editorial: Advances in drug-induced diseases
por: Liu, Yao, et al.
Publicado: (2023)

Editorial: Pharmacological interaction between drugs and medicinal plants
por: Déciga-Campos, Myrna, et al.
Publicado: (2022)

Safety of Inulin and Sinistrin: Combining Several Sources for Pharmacovigilance Purposes
por: Bui, T-V., et al.
Publicado: (2021)

Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions
por: Fleet, Jamie L, et al.
Publicado: (2013)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

Editorial: Women in drug metabolism and transport: 2021
por: Bregonzio, Claudia, et al.
Publicado: (2022)

Editorial: structural plasticity induced by drugs of abuse
por: Olive, M. Foster, et al.
Publicado: (2015)

Editorial: Orphan GPCRs As Emerging Drug Targets
por: Fang, Ye, et al.
Publicado: (2015)

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

Editorial: Biological drugs and biosimilars in autoimmune diseases
por: Wajda, Anna, et al.
Publicado: (2023)

Editorial: Molecular imaging for tracking drug delivery
por: Han, Zheng, et al.
Publicado: (2023)

Editorial: Advancements in computational studies of drug toxicity
por: Flynn, Noah R., et al.
Publicado: (2023)

Editorial: Insights in drug metabolism and transport: 2021
por: Piñeiro-Llanes, Janny, et al.
Publicado: (2023)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European Countries
por: Blonda, Alessandra, et al.
Publicado: (2022)

Editorial: Innovative pharmacometric approaches to inform drug development and clinical use
por: Garcia-Cremades, Maria, et al.
Publicado: (2023)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
por: Trostchansky, Andres, et al.
Publicado: (2022)

Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines
por: Marepally, Srujan, et al.
Publicado: (2022)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sclgbfcaabcffot7t7sid5kovb